These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1174902)
1. Aminocaproic acid and menstrual loss in women using intrauterine devices. Kasonde JM; Bonnar J Br Med J; 1975 Oct; 4(5987):17-9. PubMed ID: 1174902 [TBL] [Abstract][Full Text] [Related]
2. Effect of ethamsylate and aminocaproic acid on menstrual blood loss in women using intrauterine devices. Kasonde JM; Bonnar J Br Med J; 1975 Oct; 4(5987):21-2. PubMed ID: 1174906 [No Abstract] [Full Text] [Related]
3. Treatment of IUD related menorrhagia by indomethacin. Yarkoni S; Anteby SO Clin Exp Obstet Gynecol; 1984; 11(4):120-2. PubMed ID: 6437699 [TBL] [Abstract][Full Text] [Related]
4. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices. Ylikorkala O; Viinikka L Br J Obstet Gynaecol; 1983 Jan; 90(1):78-83. PubMed ID: 6336951 [TBL] [Abstract][Full Text] [Related]
5. Menorrhagia associated with the wearing of IUD--the results of treatment with clomiphene citrate. Bahari CM; Gorodesky IG; Neri A; Schachter A Eur J Obstet Gynecol Reprod Biol; 1982 Dec; 14(3):179-85. PubMed ID: 7160528 [TBL] [Abstract][Full Text] [Related]
6. [Treatment by tranexamic acid in menorrhagia in women using intrauterine devices]. Bengtsson LP; Weström L Lakartidningen; 1971 Aug; 68(33):3685-91. PubMed ID: 5129410 [TBL] [Abstract][Full Text] [Related]
8. [Prevention and treatment of intrauterine device caused abnormal menstruation by huan-an powder]. Liu RF Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Jun; 14(6):340-2, 324. PubMed ID: 8000221 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices. Bonnar J; Kasonde K; Haddon M; Hassanein MK; Allington MJ Br J Obstet Gynaecol; 1976 Feb; 83(2):160-4. PubMed ID: 148902 [TBL] [Abstract][Full Text] [Related]
10. Letter: Alleviation of IUD menorrhagia with ethamsylate. Harrison RF; Campbell S Br Med J; 1976 Mar; 1(6010):649-50. PubMed ID: 766907 [TBL] [Abstract][Full Text] [Related]
11. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study. Wildemeersch D; Schacht E Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of etamsylate in intrauterine-device menorrhagia. Kovács L; Annus J Gynecol Invest; 1978; 9(4):161-5. PubMed ID: 374202 [TBL] [Abstract][Full Text] [Related]
14. Menstrual bleeding pattern and iron status in women fitted with copper and non-medicated intrauterine contraceptive devices. Oyelola OO; Okonofua FE; Adediran TO East Afr Med J; 1994 Apr; 71(4):268-70. PubMed ID: 8062778 [TBL] [Abstract][Full Text] [Related]
15. Antifibrinolytic control of menorrhagia after I.U.D. insertion. MacMath IF Practitioner; 1973 Mar; 210(257):417-20. PubMed ID: 4571360 [No Abstract] [Full Text] [Related]
17. Role of prostaglandins in IUD-associated uterine bleeding--effect of a prostaglandin synthetase inhibitor (ibuprofen). Roy S; Shaw ST Obstet Gynecol; 1981 Jul; 58(1):101-6. PubMed ID: 7243136 [TBL] [Abstract][Full Text] [Related]
18. Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors. Anderson AB; Haynes PJ; Guillebaud J; Turnbull AC Lancet; 1976 Apr; 1(7963):774-6. PubMed ID: 56590 [TBL] [Abstract][Full Text] [Related]
19. Management of IUD-associated menorrhagia in female rhesus monkeys (Macaca mulatta). Barthwal M; Srivastava K Adv Contracept; 1991 Mar; 7(1):67-76. PubMed ID: 1908176 [TBL] [Abstract][Full Text] [Related]